Sökning: (WFRF:(Glimelius Bengt)) srt2:(2000-2004)
> (2002) >
A population-based ...
-
Amini, Rose-MarieUppsala universitet,Institutionen för onkologi, radiologi och klinisk immunologi,Department of Oncology, Regional Oncological Centre, University Hospital of Uppsala, Sweden, Department of Pathology, University of Uppsala, Akademiska sjukhuset, S-751 85 Uppsala, Sweden
(författare)
A population-based study of the outcome for patients with first relapse of Hodgkin's lymphoma
- Artikel/kapitelEngelska2002
Förlag, utgivningsår, omfång ...
-
2002-06-19
-
Wiley,2002
-
printrdacarrier
Nummerbeteckningar
-
LIBRIS-ID:oai:DiVA.org:liu-46949
-
https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-46949URI
-
https://doi.org/10.1034/j.1600-0609.2002.01565.xDOI
-
https://lup.lub.lu.se/record/334548URI
-
https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-89777URI
-
http://kipublications.ki.se/Default.aspx?queryparsed=id:18435058URI
Kompletterande språkuppgifter
-
Språk:engelska
-
Sammanfattning på:engelska
Ingår i deldatabas
Klassifikation
-
Ämneskategori:ref swepub-contenttype
-
Ämneskategori:art swepub-publicationtype
Anmärkningar
-
Background: Our aims were to evaluate the response to salvage treatment in relation to initial treatment and to evaluate prognostic factors at the time of relapse in an unselected population of relapsing patients with Hodgkin's lymphoma (HL). Patients and methods: In total, 124 patients younger than 60 yr of age with initial diagnosis of HL in Sweden relapsed between 1985 and 1995. Results: Fifty-eight patients relapsed after initial treatment with radiotherapy (RT) only, 62 after combination chemotherapy (CT), of whom 30 had received additional involved-field RT, and four after a short course of CT followed by extended-field RT. For 37 patients among the 58 relapsers after initial RT treated according to the recommendations of the National guidelines, the 5-yr Hodgkin-specific survival (HLS) was 85%, overall survival (OS) 73% and event-free survival (EFS) 62%, which is not inferior to survival in patients with primarily advanced stages. It was poorer in the 21 patients who initially had received RT only, even though they had been recommended for more extensive treatment. For patients initially treated with a full course (6-8 cycles) of CT the 5-yr HLS was 60%, OS 58% and EFS 22%. Bulky disease and age at diagnosis strongly affected survival in a multivariate analysis. Conclusions: Patients initially treated with RT who relapse have a favourable outcome, provided they have been treated according to the recommendations of the guidelines at the time of diagnosis. Initially bulky disease and, as a consequence, additional RT as part of the initial treatment negatively affect survival at relapse in patients initially treated with a full course of CT.
Ämnesord och genrebeteckningar
Biuppslag (personer, institutioner, konferenser, titlar ...)
-
Glimelius, BengtKarolinska Institutet,Uppsala universitet,Institutionen för onkologi, radiologi och klinisk immunologi,Department of Oncology, Regional Oncological Centre, University Hospital of Uppsala, Sweden(Swepub:uu)bengglim
(författare)
-
Gustavsson, AnitaLund University,Lunds universitet,Bröstcancer-genetik,Sektion I,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Breastcancer-genetics,Section I,Department of Clinical Sciences, Lund,Faculty of Medicine,Department of Oncology, Regional Oncological Centre, University Hospital of Lund, Sweden(Swepub:lu)onk-agu
(författare)
-
Ekman, T.Department of Oncology, Regional Oncological Centre, University Hospital of Göteborg, Sweden
(författare)
-
Erlanson, M.Department of Oncology, Regional Oncological Centre, University Hospital of Umeå, Sweden
(författare)
-
Haapaniemi, E.Uppsala universitet,Östergötlands Läns Landsting,Onkologiska kliniken,Institutionen för onkologi, radiologi och klinisk immunologi
(författare)
-
Enblad, GunillaUppsala universitet,Institutionen för onkologi, radiologi och klinisk immunologi,Department of Oncology, Regional Oncological Centre, University Hospital of Uppsala, Sweden(Swepub:uu)gunienbl
(författare)
-
Uppsala universitetInstitutionen för onkologi, radiologi och klinisk immunologi
(creator_code:org_t)
Sammanhörande titlar
-
Ingår i:European Journal of Haematology: Wiley68:4, s. 225-2320902-44411600-0609
Internetlänk
Hitta via bibliotek
Till lärosätets databas